PharmaVOICE SHOWCASE: Supply Chain Management: The Supply Chain: Risks and Opportunities with Executive Viewpoints from Ancillare’s CEO

PharmaVOICE SHOWCASE: Supply Chain Management: The Supply Chain: Risks and Opportunities with Executive Viewpoints from Ancillare’s CEO

COVID-19 caused shockwaves throughout the global supply chain of every industry. For the pharmaceutical industry, the pandemic highlighted the fragility of the supply chain and the importance of being able to adjust to demand in a changed environment.

“A fully integrated clinical trial ancillary supply chain (CTASC) relies on strategic partners, infrastructure, and information technologies that simplify communication and streamline exchanges of information among multiple parties.” said Dr. Joanne Santomauro, Ancillare CEO and Founder.

As published in PharmaVOICE

PharmaVOICE Technology Solutions: Disrupting Innovations with Digital Solutions with Executive Viewpoints from Ancillare’s CIO

PharmaVOICE Technology Solutions: Disrupting Innovations with Digital Solutions with Executive Viewpoints from Ancillare’s CIO

Healthcare is undergoing a massive transformation with increased emphasis on digital technologies in all areas. According to Deloitte research, biopharma companies recognize that digital transformation will aid product and service innovation, greater customer engagement, and improvements across R&D, commercial, and the supply chain.

“Now, Internet of Things (IoT) devices are ubiquitous. It has quickly become critical to capture patient data remotely using IoT devices.” said Deighton Liverpool, Ancillare CIO. “Organizations that can capture this data, and create algorithmic capabilities using AI and machine learning to mine and interpret it, will shape our work and lives going forward.”

As published in PharmaVOICE

Tackling Ancillary Supply Challenges with Innovative Solutions

Tackling Ancillary Supply Challenges with Innovative Solutions

When a pharmaceutical client came to Joanne Santomauro nearly 15 years ago with a request to help with a complex and expensive ancillary supply challenge, she didn’t hesitate. She launched Ancillare and began the journey to create and revolutionize ancillary supply chain management for the clinical research industry.

“Pharma companies are looking for better, faster, less expensive ways to bring a new drug to market, ancillary supply is one piece of that equation,” Joanne says.
As published in PharmaVOICE